Table 3

Spearman correlation coefficients and quantile regression models of the degree of spousal concordance in pathophysiological markers and type 2 diabetes risk factors

nrs (95% CI)MenWomen
nAge-adjustedMultivariable-adjustednAge-adjustedMultivariable-adjusted
Beta coefficient (95% CI)Beta coefficient (95% CI)
Risk factors
 Physical activity dimensions
  Time in LPA2480.27 (0.14 to 0.38)2460.28 (0.13 to 0.58)0.33 (0.12 to 0.59)2410.22 (0.11 to 0.34)0.18 (0.16 to 0.33)
  Time in HPA2480.36 (0.24 to 0.47)2460.34 (0.20 to 0.48)0.35 (0.23 to 0.43)2410.30 (0.14 to 0.59)0.28 (0.09 to 0.53)
  Sedentary time2480.17 (0.03 to 0.29)2460.21 (−0.01 to 0.39)0.22 (0.01 to 0.37)2410.16 (−0.02 to 0.31)0.11 (−0.02 to 0.34)
 Diet indicators
  Dutch Healthy Diet Index3070.42 (0.33 to 0.52)2630.45 (0.28 to 0.61)0.42 (0.31 to 0.54)2480.35 (0.21 to 0.51)0.29 (0.19 to 0.45)
  Total energy intake3070.26 (0.15 to0.36)2630.25 (0.12 to 0.50)0.28 (0.12 to 0.47)2480.32 (0.21 to 0.43)0.30 (0.18 to 0.41)
 Adiposity measures
  BMI3260.33 (0.24 to 0.42)2720.31 (0.16 to 0.35)0.26 (0.20 to 0.35)2540.21 (0.15 to 0.45)0.21 (0.05 to 0.35)
  Percentage of body fat3250.24 (0.14 to 0.34)2710.33 (0.10 to 0.48)0.28 (0.06 to 0.49)2530.20 (0.04 to 0.33)0.18 (0.01 to 0.28)
  Waist circumference3260.32 (0.22 to 0.43)2720.36 (0.24 to 0.48)0.19 (0.07 to 0.32)2540.20 (0.13 to 0.41)0.19 (0.10 to 0.35)
  Waist to hip ratio3260.21 (0.09 to 0.32)2720.24 (0.03 to 0.39)0.09 (−0.06 to 0.31)2540.18 (0.07 to 0.34)0.19 (0.00 to 0.30)
Pathophysiological markers
 Matsuda Index2690.16 (0.03 to 0.28)2330.06 (−0.05 to 0.13)−0.00 (−0.08 to 0.11)2250.19 (0.05 to 0.41)0.11 (−0.03 to 0.27)
 HOMA2-IR3020.19 (0.07 to 0.30)2630.21 (0.03 to 0.49)0.07 (−0.01 to 0.30)2530.13 (0.02 to 0.34)0.09 (0.03 to 0.19)
 C-peptidogenic indext302700.10 (−0.01 to 0.22)2340.03 (−0.02 to 0.13)0.03 (−0.03 to 0.12)2260.16 (0.05 to 0.43)0.15 (0.03 to 0.42)
 Rate sensitivity2330.11 (−0.01 to 0.24)2020.18 (−0.10 to 0.32)0.17 (−0.09 to 0.28)1970.11 (−0.06 to 0.22)0.13 (−0.07 to 0.20)
 C peptide AUC2690.07 (−0.05 to 0.19)2330.13 (−0.09 to 0.24)0.07 (−0.04 to 0.20)2250.05 (−0.05 to 0.32)0.05 (−0.07 to 0.31)
 Glucose sensitivity2730.09 (−0.02 to 0.21)2390.04 (−0.09 to 0.33)0.07 (0.01 to 0.18)2310.04 (−0.09 to 0.26)0.03 (−0.12 to 0.22)
 Potentiation factor284−0.00 (−0.11 to 0.11)2460.01 (−0.11 to 0.07)0.00 (−0.14 to 0.07)2370.03 (−0.14 to 0.17)0.09 (−0.10 to 0.19)
 Disposition index2680.23 (0.10 to 0.35)2320.12 (0.04 to 0.24)0.09 (−0.01 to 0.16)2240.26 (0.20 to 0.52)0.15 (0.01 to 0.48)
Glucose metabolism indicators
 Fasting glucose3260.25 (0.14 to 0.34)2800.37 (0.07 to 0.56)0.30 (0.05 to 0.51)2690.17 (0.06 to 0.30)0.12 (0.05 to 0.22)
 2-hour plasma glucose3080.15 (0.03 to 0.27)2760.15 (−0.00 to 0.31)0.07 (−0.02 to 0.16)2620.06 (0.01 to 0.18)0.10 (−0.05 to 0.16)
 Hemoglobin A1c3240.20 (0.09 to 0.30)2820.23 (0.01 to 0.36)0.15 (−0.05 to 0.30)2670.10 (−0.04 to 0.22)0.08 (−0.00 to 0.19)
  • rs is Spearman correlation coefficient.

  • Physical activity dimensions were adjusted for age, educational level, alcohol use and smoking status. The Dutch Healthy Diet Index was adjusted for age, educational level, waist circumference, smoking status and total energy intake. Adiposity measures were adjusted for age, time in HPA, smoking status, Dutch Healthy Diet Index and educational level. Pathophysiological markers were adjusted for age, waist circumference, time in HPA and family history of diabetes.

  • AUC, area under the curve; BMI, body mass index; HOMA2-IR, Homeostatic Model Assessment of Insulin Resistance; HPA, high-intensity physical activity; LPA, low-intensity physical activity.